Stay updated on Amivantamab & Lazertinib in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Amivantamab & Lazertinib in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Amivantamab & Lazertinib in NSCLC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The website has been updated with new additions including a revision to v2.14.1 and estimated last update dates, while the previous version v2.14.0 and several October 2024 entries have been removed.
    Difference
    0.7%
    Check dated 2025-01-19T22:57:35.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.
    Difference
    0.2%
    Check dated 2025-01-12T18:26:40.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    No Change Detected
  6. Check
    42 days ago
    Change Detected
    Summary
    The website has been updated from version v2.13.2 to v2.13.3.
    Difference
    0.1%
    Check dated 2024-12-14T22:46:56.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Summary
    The website has updated the contact details section for the study, clarifying that it now provides information for those interested in joining the study, along with a reference to the Contacts and Locations section.
    Difference
    2%
    Check dated 2024-12-07T16:21:52.000Z thumbnail image
  8. Check
    64 days ago
    Change Detected
    Summary
    Several key URLs related to genetics, lung cancer, and clinical trial data have been removed, indicating a potential shift in focus or resource availability on the website.
    Difference
    3%
    Check dated 2024-11-23T04:49:50.000Z thumbnail image
  9. Check
    71 days ago
    Change Detected
    Summary
    New resources related to genetics and lung cancer have been added, including links to MedlinePlus and DailyMed, which may be of particular interest for health information and drug details.
    Difference
    0.3%
    Check dated 2024-11-16T00:01:28.000Z thumbnail image

Stay in the know with updates to Amivantamab & Lazertinib in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Amivantamab & Lazertinib in NSCLC Clinical Trial page.